Although the use of rituximab can improve the prognosis of patients with transformed lymphoma [ 3 , 15 ], the accurate and effective prediction of HT remains a highly significant scientific challenge.
← all excerpts
A rare case of splenic marginal zone lymphoma with MYD88 mutation transformed into diffuse large B-cell lymphoma: case report and literature review.
1
—
—